logo
Invasive, parasitic fish in Great Lakes thrived during COVID-19

Invasive, parasitic fish in Great Lakes thrived during COVID-19

Yahoo15-04-2025

COLUMBUS, Ohio (WCMH) — A study has revealed the effect of the COVID-19 pandemic on an invasive parasitic fish that wounds and kills Great Lakes native species like lake trout, whitefish, ciscoes, and walleye.
According to the Great Lakes Fishery Commission, the sea lamprey feeds on the blood and fluids of other fish by attaching itself with its sharp tongue. The aquatic pest has been wreaking havoc since entering the region from the Atlantic Ocean more than 150 years ago. Experts note that one sea lamprey can kill up to 40 pounds of fish in its parasitic stage. At its most prolific nearly 75 years ago, almost 2.5 million sea lampreys killed 100 million pounds of fish annually.
Watch: JD Vance fumbles Buckeyes' national championship trophy
In the 1950s, a sea lamprey control program began, which led to populations plummeting to about '10% of their historic highs.' However, COVID-era travel restrictions impeded efforts to reduce or eliminate the creature.
Study authors, who published their findings in the journal 'Fisheries,' sought to discover if sea lampreys still 'posed a threat to Great Lakes fisheries' or if 'sea lamprey control [was] still necessary to suppress their populations.'
'When life gives you lemons, make lemonade,' said Dr. Nick Johnson, a research ecologist with the U.S. Geological Survey and a co-author on the study. 'When the COVID-19 pandemic significantly reduced sea lamprey control for two years, our research team made the most of the situation by using it as an unplanned experiment to learn valuable information — nearly impossible to obtain otherwise — about the current impact of control on sea lamprey populations.'
The team of 15 scientists found that reductions in applying lampricide, a 'pesticide highly selective to lampreys,' in 2020 and 2021 allowed the organism's population to explode.
Marion named nation's Strongest Town
'Like a coiled spring, sea lamprey populations bounced back quickly when control was relaxed,' said Dr. Ben Marcy-Quay, a fish biologist with the U.S. Geological Survey and the lead author of the study. 'Wounding on Chinook and coho salmon, specifically, increased over 10-fold. Our findings support observations by the fishing public and fishery managers of fish riddled with sea lamprey wounds, some containing three or more wounds per fish.'
The Great Lakes Fishery Commission asserted that study results confirm that continued vigilance against the sea lamprey is necessary to protect 'Great Lakes fish and the valuable fisheries they support.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Omada Health IPO signals healthier market, avoids 'down-round' trend
Omada Health IPO signals healthier market, avoids 'down-round' trend

Yahoo

time2 hours ago

  • Yahoo

Omada Health IPO signals healthier market, avoids 'down-round' trend

The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic conditions like diabetes and hypertension between office visits, closed its first trading day on Friday at $23 a share, a 21% jump from the IPO price of $19. The IPO valued the company just above $1 billion (excluding employee options), a figure that's nearly identical to Omada's last private valuation of $1 billion set in its previous VC round. The debut is one of the first among recent IPOs that was not a so-called down-round. Many of the latest public listings, including Hinge, ServiceTitan, and Reddit, priced below their private market highs, though have faired well as public companies. For founder and CEO Sean Duffy, the successful public offering validates his decision to start a company that he believed the market desperately needed. In 2011, he dropped out of Harvard Medical School after realizing that chronic illness patients required more continuous support than the existing healthcare system delivered. Before the offering, he owned 4.1% of the company, according to Omada's offering document. Other significant shareholders included Revelation Partners (10.9%), US Venture Partners (9.9%), Andreessen Horowitz (9.6%), and FMR (9.3%). Duffy told TechCrunch that over his 14-year journey as a founder, he had many harrowing moments. "I didn't think our series A was going to come together because we were working on this commercial deal that didn't materialize, and that spooked one investor," he said. "As a young business, something tries to kill you every month," he continued. "And then as the business grows, it turns into like every quarter or six months, year, two years." One of the recent challenges for many digital health businesses is navigating the "collapse" of the market post-COVID boom. Omada steered through the turbulent times by seeking new, rising markets. It recently expanded its offerings to include diet management support for GLP-1 patients.

Chillicothe girl with brain injury from flu complications returns home
Chillicothe girl with brain injury from flu complications returns home

Yahoo

time3 hours ago

  • Yahoo

Chillicothe girl with brain injury from flu complications returns home

CHILLICOTHE, Ohio (WCMH) — A Chillicothe family is grateful to have their little girl back home, but now they have a long and expensive road ahead of them. NBC4 first reported on Locklynn Boler at the beginning of March. At just 4 years old, she fell into a coma for weeks due to severe complications from the flu. She has fortunately recovered from it, but will never be the same again due to the brain injury she suffered from the coma. 'You see all these kids dying from this, and somehow she made it,' said Bradley Boler, Locklynn's father. That's because Locklynn was born a fighter. 'She's been through it since the day she was born,' Boler said. 'She had issues with her kidneys well before all of this.' Boler said its been a constant battle since Locklynn woke up from her coma. Her brain injury has left her unable to walk, talk or eat on her own. Since then, she's been in and out of Nationwide Children's Hospital. 'She's on like 20 different meds,' Boler said. 'She takes a massive med pass at 8 p.m. and 8 a.m. She has to get vest treatments multiple times a day.' The bills have been piling up for the Boler family. They're in the process of making their home wheelchair-accessible for Locklynn. 'The plan now is we wound up getting a van finally,' Boler said. 'We want to try to get one with a lift, as well as getting another ramp built on to the back porch.' Locklynn now needs around-the-clock care. One of the Boler family's biggest struggles was finding a nurse, but their prayers have been answered. 'My sister quit her job to take care of Locklynn,' Boler said. 'We owe her the world.' Boler said they're grateful for the outpouring of love and support from the community. Fundraisers for their family have brought in close to $11,000. All of that money is being put toward necessary modifications to make Locklynn as comfortable as possible as she adapts to her new normal. Local organizations like the Mid-Ohio Board for an Independent Living Environment (MOBILE) have also stepped up to provide resources. 'Value your time with your kids,' Boler said. 'I spent a lot of the last year working 70 to 80 hours a week. Spend more time with your kids. You never know. It could happen to anybody.' While Locklynn will never be the little girl her family once knew, they said they love this new version of her just as much. 'She's amazing,' Boler said. 'That's all I can say. She's the strongest kid I've ever met in my life.' The Boler family is still raising funds to be able to make the necessary modifications to their home for Locklynn. They're selling #LocklynnStrong t-shirts. You can purchase one here. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Migratory birds develop antibodies to bird flu, officials say
Migratory birds develop antibodies to bird flu, officials say

Yahoo

time6 hours ago

  • Yahoo

Migratory birds develop antibodies to bird flu, officials say

(WAVY) – Wildlife officials are keeping a close eye on the spread of avian influenza after along the North Carolina coast earlier this year — most of them brown pelicans. The outbreak has since been linked to the H5N1 strain of bird flu, a virus that continues to mutate and occasionally jump to other species, raising concern among experts. Miranda Turner, a wildlife health biologist with the North Carolina Wildlife Resources Commission, said the area is a prime wintering ground for birds — making it easier for disease to spread. 'When you bring a lot of animals together and you have them traveling from different locations, it's a really good way to transmit diseases,' Turner said. In Hampton Roads, bird flu outbreaks aren't new. Lisa Barlow, president of T recalls treating sick and dying Canada geese during a 2021 outbreak on the Lafayette River. 'We dealt with about three to four dozen Canada geese that came in sick and dying,' Barlow said. 'Only six survived the flu, and even those had to be euthanized due to severe neurological symptoms.' Barlow described birds arriving unable to hold their heads up, their beaks caked in mud. Many died within 24 hours. As the virus continues to affect wildlife, it's not just birds at risk. , including seals, cats and even cattle. Experts say it's mutated at least several times since it was first identified. 'I mean, anything that can do that — it's kind of frightening, but amazing,' Barlow said. Despite the concerning spread, health officials emphasize the risk to humans remains low. According to the Centers for Disease Control and Prevention, 70 human cases have been reported nationwide, including one death. Most infections have been among people with repeated exposure to infected animals, such as poultry or dairy farm workers. 'There's really low risk,' Turner said. 'Still, it's a good idea to clean bird feeders regularly and wear gloves or a mask if you handle injured wildlife.' Barlow also urges caution for those who come across sick birds. 'If you do want to help, wear gloves, protect yourself,' she said. 'Common sense goes a long way.' Meanwhile, as migratory birds continue to interact and spread the virus, some are developing natural antibodies, according to Turner. 'They're bouncing back and creating herd immunity,' she said. Last week, the Associated Press reported the in funding meant to support Moderna's development of a bird flu vaccine. The vaccine, which uses mRNA technology similar to the COVID-19 vaccine, had shown early promise in clinical trials. For now, wildlife officials say they expect to see more outbreaks in the years ahead, especially during peak migration periods. 'Because this virus is so common in migratory birds, it is likely that we will continue to see cases here and there every winter,' Turner said. As of right now, there have been no confirmed human cases of H5N1 in Virginia and although the risk remains low for humans, for birds it can be extremely deadly – leading to large die-off events like the ones we saw near Cape Hatteras. 'Unfortunately, this was the first kind of major large scale mortality event… while it looks really bad at that small scale of seeing 300 brown pelicans die – it's not impacting their population as a whole or the species as a whole,' adds Turner. Turner also explains that the surviving pelicans are still there, 'The brown pelicans that did survive that event were still nesting on that island successfully and are doing well. So really, it's a short scale kind of scary looking event, but nothing that raises alarm for biologists in the long term.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store